Skip to content
Menu

Aditxt, Inc. ADTX

Full chart Compare
Set alert

Price alert · ADTX

All alert types
0.00 USD 0.00 (+50.00%)

Regular-session close

0.01 +0.01 +2,466.67%

After hours · Nov 19, 4:00 PM ET

0.0001 Day range 0.0018
0.00 52-week range 896.40
YTD
-25.00%
1 year
-25.00%

Fundamental scorecard

0 of 25 checks passed on ADTX’s reported financials

ValueGrowthProfitabilityHealthDividend

0of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 0 of 5
  • Dividend 0 of 5

Statements to Mar 31, 2026.

Value 0 of 5

  • Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
  • Failed:P/E under 20 No profit over the last 12 months, so no P/E.
  • Failed:Price to sales below its own 5-year median Price to sales 20.9 against a 5-year median of 20.1.
  • Failed:Price to book below its own 5-year median Shareholders’ equity is negative.
  • Failed:Free cash flow yield above 4% Free cash flow of -18.6M is -6205.2% of the market value.

Growth 0 of 5

  • Failed:Revenue grew over the last year Revenue of 14.3K is -74.1% on the 12 months before.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Failed:Earnings per share grew over the last year EPS 112029.51 against 1889027265.02 in the 12 months before.
  • Failed:Earnings per share grew more than 5% a year over five years EPS -649252800156.00 in FY 2020, -31153.00 in FY 2025.
  • Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -101.8% on the last 12 months.

Profitability 0 of 5

  • Failed:Profitable over the last year Net income of -54.7M over the last 12 months.
  • Failed:Profitable in each of the last five fiscal years A profit in 0 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Shareholders’ equity is negative.
  • Failed:Net margin above its 5-year average Net margin of -381739.1% against a 5-year average of -295821.8%.
  • Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.

Financial health 0 of 5

  • Failed:Short-term assets cover short-term liabilities Short-term assets of 850K against short-term liabilities of 13.3M.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 850K against long-term liabilities of 35.7M.
  • Failed:Net debt under 40% of equity Shareholders’ equity is negative.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -18.6M is -438.2% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is -95.8 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What ADTX owns and owes, as of Mar 31, 2026

Short term and long term

Balance sheet · 13.9M of assets

Liabilities exceed assets, so there is no shareholders’ equity to show.

Debt, equity and cash by year

Now: 3.90M of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-35.89 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.2×
P/S 2109×
P/B 1.2×
P/FCF -0.0×
EV/EBITDA -0.2×
EV/Sales 2049×
FCF Yield -381486.9%

Profitability

Gross Margin 8.4%
Operating Margin -612542.2%
Net Margin -1305608.8%
ROE -743.6%
ROIC -281.2%
ROA -252.6%

Growth (YoY)

Revenue -97.6%
Operating Income 29.8%
EPS (diluted) 62.3%
Free Cash Flow -153234.4%

Financial Health

Current Ratio 0.3×
Quick Ratio 0.3×
Debt / Equity 0.5×
Net Debt / EBITDA 0.0×
Interest Coverage -8.2×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31